DreaMed Advisor

The DreaMed diabetes device
FDA greenlights DreaMed's AI-backed insulin management tool for folks with Type 2 diabetes
By Emily Olsen | 12:12 pm | October 07, 2021
The latest approval marks DreaMed’s fourth clearance from the Food and Drug Administration.
FDA grants DreaMed's de novo request for device-friendly diabetes software
By Dave Muoio | 09:52 am | June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes.